Chronic respiratory diseases are one of the three major diseases that threaten human health and a core challenge affecting human quality of life. Traditional treatments often rely on medication or invasive interventions, which may not only cause side effects but also fail to improve cellular health at its root. Hydrogen-oxygen therapy is gradually gaining attention. This therapy involves inhaling a specific mixture of hydrogen and oxygen gases, helping to improve health at the cellular level, reduce inflammation and oxidative damage, and providing an innovative solution for the prevention and treatment of chronic respiratory diseases.
The core of hydrogen therapy lies in the unique biological properties of hydrogen gas. Hydrogen is the smallest molecule known to date, capable of rapidly diffusing into cells and organelles. Studies have shown that hydrogen has selective antioxidant effects, precisely neutralizing the most harmful reactive oxygen species, such as hydroxyl radicals (·OH) and peroxynitrite anions, thereby reducing inflammation and cell damage caused by oxidative stress.
Unlike traditional antioxidants, hydrogen does not interfere with the body's normal physiological redox reactions and only acts on harmful free radicals, thus offering better safety.
Research on hydrogen-oxygen therapy in the field of respiratory diseases
Hydrogen-oxygen therapy first gained clinical attention in the field of respiratory medicine. By scavenging excess harmful free radicals, hydrogen gas can reduce oxidative damage to the airways and alveoli, thereby alleviating inflammatory responses and improving airway patency to some extent.
Acute exacerbation of COPD: A multicenter, randomized, double-blind controlled trial showed that the change in BCSS score (Breathlessness, Cough, and Sputum Scale) was greater in the hydrogen-oxygen group than in the oxygen group, meeting the superiority criteria. This demonstrates that hydrogen-oxygen therapy can safely and effectively relieve symptoms in patients with AECOPD and can be used as an alternative to long-term home oxygen therapy.
Asthma: Inhaling high concentrations of hydrogen can effectively alleviate pathological changes in lung tissue and has an auxiliary effect on ovalbumin-induced asthma in rats. It reduces airway inflammatory infiltration and goblet cell hyperplasia, increases superoxide dismutase activity, and lowers inflammatory cytokine levels.
Pulmonary nodules: Phase IV clinical studies show that hydrogen-oxygen therapy has an efficacy rate of over 90% in reducing the size of pulmonary nodules, especially for benign nodules and precancerous lesions. It can effectively slow down the progression of nodules and avoid unnecessary surgery.
COVID-19: A retrospective, multicenter clinical study led by Academician Zhong Nanshan and conducted across dozens of designated COVID-19 hospitals in China has confirmed that inhaling a hydrogen-oxygen mixture can alleviate symptoms such as shortness of breath, shorten hospital stays, improve blood oxygen saturation, and reduce the incidence of severe cases.
It is important to emphasize that hydrogen-oxygen therapy is currently primarily used as an adjunctive treatment and cannot replace standard treatment regimens such as bronchodilators, corticosteroids, or anti-infective medications.
Asclepius Meditec Hydrogen-Oxygen Generator: The indispensable core equipment for hydrogen-oxygen therapy.
As a pioneer in the field of hydrogen-oxygen medicine, Asclepius Meditec has focused on hydrogen-oxygen technology research and development since 2011, accumulating 459 global patents and collaborating with numerous top hospitals, resulting in the publication of 106 academic papers. The superior performance of the Asclepius hydrogen-oxygen machine stems from fifteen years of technological accumulation and continuous innovation, with its core technological advantages evident in several aspects:
This innovative "membrane-free, alkali-free" electrolysis technology breaks through the limitations of traditional industrial hydrogen production. It eliminates the need for toxic ion membranes or the addition of strong industrial alkalis, producing high-purity hydrogen and oxygen mixed gas solely through the electrolysis of pure water. This avoids problems such as ozone and toxic impurities that can arise from traditional industrial hydrogen production equipment, ensuring the safety of the inhaled gas. This technology was also nominated for the 2020 Shanghai Science and Technology Progress Special Award.
Multiple Safety Protection Design: Addressing the highly flammable and explosive nature of hydrogen gas, the product utilizes several patented technologies, including zero-gas-chamber storage, multiple explosion-proof features, and electrostatic discharge mechanisms. Combined with a wearable bracelet that monitors 24 physiological indicators, it meets the highest safety standards and ensures long-term safe operation.
Precise Concentration Control: The device stably outputs a mixed gas of 66.66% hydrogen and 33.33% oxygen, with minimal concentration error, ensuring the stability and reliability of the treatment effect.
Compact and Portable Design: As the world's smallest and highest-output medical-grade hydrogen-oxygen generator, the product weighs only 12-18kg and has a compact design. Available in models for medical institutions and home use, it is suitable for various settings such as homes and hospitals, allowing users to easily perform hydrogen-oxygen inhalation anytime.
Long lifespan and low consumables: The entire machine has undergone a 50,000-hour accelerated aging test, and can be used for more than 10 years under normal operation. It only requires the use of specialized purified water, resulting in low consumable costs and low maintenance costs, making it highly cost-effective for long-term use.
Its main products include:
* AMS-H-03 Hydrogen-Oxygen Nebulizer: Class III medical device, adjustable flow rate (2.0 / 2.5 / 3.0 L/min), dimensions 470×240×490 mm, suitable for hospitals, clinics, and rehabilitation centers.
* AMS-H-01 Hydrogen-Oxygen Nebulizer: Class III medical device, three-level touch control adjustment (2 / 2.5 / 3 L/min), dimensions 450×245×485 mm, suitable for respiratory, sleep, and geriatric departments.
* AMS-H-03/30C Hydrogen-Oxygen Nebulizer: Class III medical device, supports voice control (2 / 2.5 / 3 L/min), dimensions 285×285×385 mm, suitable for pharmacies, clinics, health management institutions, and home use.
* BYT-OA-01 Hydrogen Water Generator with Hydrogen Water Bottle: Gas production 1000 ml, suitable for home and office use.
* BYT-CK-01 Portable Hydrogen Oxygen Generator: Gas production 300 ml, portable design, suitable for use in cars and while traveling.
All devices undergo rigorous safety testing to ensure non-toxic and low-noise operation. Compared to homemade devices or non-medical grade products, professional medical-grade hydrogen-oxygen inhalers are crucial for guaranteeing efficacy and user safety.
If you are interested in hydrogen-oxygen therapy and need recommendations for professional, medical-grade hydrogen-oxygen breathing machines, please leave a message and contact Asclepius Meditec.
